About albuterol + ipratropium bromide
Short-acting bronchodilator combination
Used for
- Relieves wheezing and breathlessness in chronic obstructive pulmonary disease (COPD).
Usual adult dose
One nebulised unit dose (salbutamol 2.5 mg plus ipratropium 0.5 mg), usually three or four times daily; follow local product instructions.
Usual dose in children
Not routinely used in children; dosing depends on age and clinical setting.
Common side effects
- Tremor, headache, or dizziness
- Dry mouth or throat irritation
- Fast heartbeat or palpitations
- Cough or nausea
Important warnings
- May rarely cause worsening wheezing immediately after inhalation; seek urgent care if severe.
- Avoid getting mist in the eyes; it may worsen narrow-angle glaucoma.
- Use caution with heart disease, abnormal heart rhythms, or overactive thyroid.
- Frequent or increasing use may signal worsening breathing disease.
Pregnancy
Use only when clinically needed; pregnancy data are limited. A clinician should weigh benefits and risks.
Breastfeeding
Use with caution; inhaled doses generally cause low exposure, but clinical advice is appropriate.
Interactions
- Other anticholinergic medicines may increase dry mouth, blurred vision, or urinary problems.
- Other beta-agonists or stimulants may increase fast heartbeat or tremor.
- Beta-blockers may reduce bronchodilator effect and can provoke bronchospasm.
- Diuretics or digoxin may increase risks of low potassium or heart rhythm problems.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.